A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

Clinical trial NCT06370351 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06370351
Sponsor: Sensorion
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

OTOF Gene Mutation DFNB9 Congenital Deafness Hearing Disorders Ear Diseases Otorhinolaryngologic Diseases Deafness Hearing Loss, Sensorineural

Start date: 2024-06-21
Primary completion: 2027-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.